Alembic Pharmaceuticals is planning to raise capital through way of issuance of Non-Convertible Debentures (NCDs) on Private Placement Basis. The Board of Directors of the Company at its meeting to be held on June 12, 2019 to consider the same.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.